PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
PROCEPT BioRobotics Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$18.28+0.71 (+4.04%)
Close on Oct 19, 2026
- Market cap
- $1.04B
- P/E (TTM)
- –
- Dividend yield
- –
PROCEPT BioRobotics Corp revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $295.94M | $282.10M | $270.38M | $264.18M | $242.48M | $220.57M | $200.47M | $180.35M | $160.46M | $142.72M | $124.30M | $105.79M | 87.7% | +22.0% |
| Outside of U.S. | – | – | – | $35.73M | $32.47M | $28.56M | $24.03M | $19.49M | $16.11M | $13.60M | $11.89M | $10.60M | – | – |
From the segment and revenue-disaggregation notes of PROCEPT BioRobotics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.